Magellan Health Inc. has revised its guidance for 2018.

The company now expects net income to be in the range of $125 million to $149 million, compared with the previous expected range of $114 million to $138 million. It is maintaining its projected revenue range at $7.5 billion to $7.8 billion.

Adjusted net income is projected to be in the range of $163 million to $183 million, compared to previous guidance of $143 million to $163 million. The company now expects adjusted EPS to be between $6.37 and $7.15, compared to the prior guidance of $5.68 to $6.47.

Magellan Health also reported fourth-quarter 2017 adjusted net income of $64.2 million, or $2.55 per share, versus $42.4 million, or $1.80 per share, in the year-ago period.